# A Chemosensory-Mechanotransduction System Regulating Ventricular Size and Brain Function > **NIH NIH R01** · UNIV OF MASSACHUSETTS MED SCH WORCESTER · 2024 · $100,611 ## Abstract Parent Grant Summary/Abstract How the brain determines cerebral ventricular volume, and how that in turn affects brain function, are poorly understood. In patients who develop idiopathic normal pressure hydrocephalus (iNPH) or low pressure hydrocephalus after intracranial hemorrhage, infection or other brain insults, ventricular volume increases in the absence of obstruction to cerebrospinal fluid (CSF) flow, sustained intracranial pressure (ICP) elevations or brain atrophy. iNPH patients display motor apraxia, dementia and incontinence that are often improved by CSF drainage, but the underlying mechanisms are not known. Numerous studies suggest that ependymal motile cilia dysfunction somehow leads to hydrocephalus, albeit via unclear mechanisms. Indeed, some investigators have challenged this notion, suggesting instead that increased CSF production, decreased CSF absorption, or abnormal brain development are responsible. Here we present evidence for an ependymal chemosensory- mechanotransduction system that uses motile cilia to convert chemical signals to changes in flow that govern ependymal cell junction assembly, ventricular wall stiffness and ependymal permeability. By controlling ventricular compliance and the exchange of CSF between the ventricular and interstitial spaces, this system regulates ventricular volume, the relative distribution and composition of fluid in the ventricular and interstitial compartments, and neuronal activity, all without altering ICP. To elucidate why ventriculomegaly and neurological deficits develop in iNPH, we sequenced DNA from iNPH patients to identify iNPH-associated mutations. Most of the iNPH-associated mutations involved genes that encode proteins associated with cilia, and all of the genes showed increased expression in ependymal or choroid plexus cells. iNPH-associated mutations affecting CWH43 or AK9 occurred in 25% of iNPH patients. Mice harboring iNPH-associated CWH43 or AK9 mutations displayed decreased motile cilia number or motility, respectively, and developed ventriculomegaly and gait imbalance characteristic of iNPH. We now show that the ventriculomegaly is accompanied by normal ICP, increased ventricular compliance and permeability, and disassembly of ependymal cell junctions. We and others have discovered multiple receptors that localize to ependymal motile cilia and regulate CSF flow by modulating cilia beat frequency. Mutation of these receptors increases ventricular volume. In normal mice, we find that flow is required to maintain ependymal cell junctions. This process involves activation of ependymal Piezo1, TRPV4, and PKD2 mechanotransduction channels. Induced conditional deletion of Piezo1 or PKD2 in adult mice increases ventricular size. We observed a diurnal increase in ependymal permeability that increases exchange between ventricular CSF and interstitial fluid during sleep. We find that ventriculomegaly in CWH43 or AK9 mutant mice is associated with a task-dependent decrease in ne... ## Key facts - **NIH application ID:** 11089887 - **Project number:** 3R01NS106985-05S1 - **Recipient organization:** UNIV OF MASSACHUSETTS MED SCH WORCESTER - **Principal Investigator:** MARK D JOHNSON - **Activity code:** R01 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 2024 - **Award amount:** $100,611 - **Award type:** 3 - **Project period:** 2024-07-01 → 2025-06-30 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/11089887 ## Citation > US National Institutes of Health, RePORTER application 11089887, A Chemosensory-Mechanotransduction System Regulating Ventricular Size and Brain Function (3R01NS106985-05S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11089887. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*